PHOENIX, Nov. 29, 2012 /PRNewswire/ -- Although molecular medicine has been lauded as a game-changing science, patients have yet to see the benefits. Until now.

On Dec. 4, one of the nation's largest children's hospitals, in collaboration with a major genomics research organization and a nationally regarded university, will announce a major venture that puts genomics research into clinical practice immediately to benefit children with terminal diagnoses.

Unlike other children's hospitals engaged in basic genomics research, the Institute of Molecular Medicine will take research to the next level, providing real-time access to drug therapies never before used in children.

What:

Announcement of a pediatric medical research institute led by an internationally respected team of physician scientists putting molecular medicine into clinical practice immediately with real-time access to drug therapies

Who:

Phoenix Children's Hospital, in collaboration with Translational Genomics Research Institute (TGen) and University of Arizona College of Medicine - Phoenix

When:

Dec. 4, 2012 3:30 p.m. EST 2:30 p.m. CST 1:30 p.m. MST 12:30 p.m. PST

Where:

Original post:

New venture puts molecular medicine into clinical practice today